United States · Funded startup
7 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$132Mraised across 7 rounds since 1999, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Mar 2012
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Oct 2010
Temasek Holdings
Scottish Equity Partners
Quest for Growth
HBM Partners
BankInvest
Merifin Capital
Quest Capital Management, Inc .Reported by evaluategroup.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Scottish Equity PartnersTemasek HoldingsUOB VentureInvesco Private CapitalQuest for GrowthNIF VenturesHBM PartnersBankInvestSociete Generale Asset ManagementMerifin CapitalMissing a round, or an investor who was in one? Tell us.
Cyclacel Pharmaceuticals's investors include Scottish Equity Partners, Temasek Holdings, UOB Venture, Invesco Private Capital and Quest for Growth, and 11 more on record.
Cyclacel Pharmaceuticals has raised $132M across 7 rounds since 1999.
Cyclacel Pharmaceuticals's most recent round was an Undisclosed round of $10M in Apr 2014.
Cyclacel Pharmaceuticals's largest round on record is $48M (Series C), in Jun 2001.
Cyclacel Pharmaceuticals's first round on record, in May 1999, was backed by Scottish Equity Partners.
Cyclacel Pharmaceuticals's latest named round is an Undisclosed round, in Apr 2014.
Cyclacel Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·